A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China. (linkinghub.elsevier.com)

Authors: Sun F … Zhang W Journal: Clinical Microbiology and Infection Published: 2026-03-01 DOI: https://doi.org/10.1016/j.cmi.2025.11.015